Show simple item record

dc.contributor.authorMorrison, Joanne
dc.date.accessioned2020-09-17T17:23:26Z
dc.date.available2020-09-17T17:23:26Z
dc.date.issued2020-08-13
dc.identifier.urihttp://hdl.handle.net/10713/13725
dc.descriptionResearchers at the University of Maryland School of Medicine (UMSOM) have begun participation in the Phase 3 clinical trial of an investigational COVID-19 vaccine co-developed by scientists at Moderna Inc. and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Video includes brief interview with UMB President, Bruce E. Jarrell, MD, FACS, who is a participant in the trial.en_US
dc.description.urihttps://youtu.be/n3w076epkK4en_US
dc.language.isoen_USen_US
dc.subjectCoronavirus Disease 2019 (COVID-19)en_US
dc.subjectModernaen_US
dc.subject.lcshCOVID-19 (Disease)en_US
dc.subject.lcshNational Institute of Allergy and Infectious Diseases (U.S.)en_US
dc.subject.lcshUniversity of Maryland, Baltimore. School of Medicineen_US
dc.subject.meshClinical Trial, Phase IIIen_US
dc.subject.meshCOVID-19 Vaccinesen_US
dc.titleCOVID-19 Vaccine Trial Begins At UMBen_US
dc.typeArticleen_US
dc.typeVideoen_US
refterms.dateFOA2020-09-17T17:23:27Z


Files in this item

Thumbnail
Name:
COVID-19VaccineTrialBeginsAtUM ...
Size:
1.055Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record